ROLE OF SERUM LEVEL IL-13 IN SYSTEMIC SCLEROSIS PATIENTS WITH INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Ovsyannikova, Olga
Koneva, Olga
Garzanova, Liudmila
Shayakhmetova, Rushana
Desinova, Oxana
Starovoytova, Mayya
Khelkovskaya-Sergeeva, Anna
Ananyeva, Lidia
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.07.101
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6502A / 6502A
页数：1
相关论文
共 50 条
  • [1] IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease
    Versace, Antonio Giovanni
    Bitto, Alessandra
    Ioppolo, Carmelo
    Aragona, Caterina Oriana
    La Rosa, Daniela
    Roberts, William Neal
    D'Angelo, Tommaso
    Cinquegrani, Antonella
    Cirmi, Santa
    Irrera, Natasha
    Navarra, Michele
    Corrao, Salvatore
    Gangemi, Sebastiano
    Bagnato, Gianluca
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Role of IL-13 in systemic sclerosis
    Fuschiotti, Patrizia
    CYTOKINE, 2011, 56 (03) : 544 - 549
  • [3] Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis
    Vesely, R
    Vargová, V
    Ravelli, A
    Massa, M
    Oleksák, E
    D'Alterio, R
    Martini, A
    De Benedetti, F
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (04) : 795 - 800
  • [4] SERUM PROTEOMIC BIOMARKERS DEFINE PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE
    De Santis, M.
    Isailovic, N.
    Ceribelli, A.
    Motta, F.
    Vecellio, M.
    Selmi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 152 - 152
  • [5] Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
    Hasegawa, M
    Fujimoto, M
    Kikuchi, K
    Takehara, K
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (02) : 328 - 332
  • [6] The relationship between serum level of matrix metalloproteinase-7 and interstitial lung disease in patients with systemic sclerosis
    Mervat M. Abo Gabal
    Noha H. Shedid
    Elham S. Mohamed
    Warda Abdelfattah
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 720 - 725
  • [7] Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis
    Huang, Xiao-Lei
    Wang, Yu-Jie
    Yan, Jun-Wei
    Wan, Ya-Nan
    Chen, Bing
    Li, Bao-Zhu
    Yang, Guo-Jun
    Wang, Jing
    INFLAMMATION RESEARCH, 2015, 64 (3-4) : 151 - 159
  • [8] Serum Neutrophil Count Predicts Progression of Interstitial Lung Disease and Mortality in Patients with Systemic Sclerosis Related Interstitial Lung Disease
    Wareing, Nancy
    Li, Ning
    Volkmann, Elizabeth
    Lyons, Marka
    Roth, Michael
    Tashkin, Donald
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis
    Xiao-Lei Huang
    Yu-Jie Wang
    Jun-Wei Yan
    Ya-Nan Wan
    Bing Chen
    Bao-Zhu Li
    Guo-Jun Yang
    Jing Wang
    Inflammation Research, 2015, 64 : 151 - 159
  • [10] Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients
    Celeste, Stefania
    Santaniello, Alessandro
    Caronni, Monica
    Franchi, Jurij
    Severino, Adirana
    Scorza, Raffaella
    Beretta, Lorenzo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (07) : 671 - 676
12345